Herts and Essex Fertility - IVF Spot Purchase NCL ICB

The procurement process for the "Herts and Essex Fertility - IVF Spot Purchase NCL ICB" has reached the award stage, with a contract awarded on 16th October 2025. This tender, categorized under the healthcare services industry and specifically in vitro fertilisation services, was conducted by NHS North Central London ICB, based in London, UK. The procurement method was limited, meaning it followed a direct award procedure without prior publication of a call for competition, as per the Health Care Services (Provider Selection Regime) Regulations 2023.

The location for the service delivery is specified within the UKH2 region, highlighting a tailored approach for service provision under the healthcare sector. This tender offers promising business opportunities, especially for enterprises operating in the healthcare and medical services domain, such as small to medium enterprises looking to provide specialised fertility services. With the focus on in vitro fertilisation, businesses that can deliver high-quality fertility treatments stand to benefit.

The procurement process favours those already established in the healthcare services sector and those who can effectively deliver services where patients have a choice of providers. This competitive contract emphasises price as the award criterion, thus encouraging affordable yet high-quality service provision. The involvement of the Herts and Essex Fertility Centre Limited, an established fertility service provider, signifies the level of expertise and capability sought by the procurement authority.